DIGNA
Desconocido
IT-LIVER: STRATEGY TO INHIBIT TGF Beta IN LIVER DISEASE
DIGNA BIOTECH, S.L
participó en un
FP7:
Chronic liver diseases (CLD) and their end-stages, cirrhosis and hepatocellular carcinoma (HCC), are leading causes of morbidity and mortali...
Financiado
Financiado
* No se disponen de datos de la empresa actual.